Literature DB >> 15197397

No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF).

D L Thiselton1, B T Webb, B M Neale, R C Ribble, F A O'Neill, D Walsh, B P Riley, K S Kendler.   

Abstract

The neuregulin-1 gene (NRG1) at chromosome 8p21-22 has been implicated as a schizophrenia susceptibility gene in Icelandic, Scottish, Irish and mixed UK populations. The shared ancestry between these populations led us to investigate the NRG1 polymorphisms and appropriate marker haplotypes for linkage and/or association to schizophrenia in the Irish study of high-density schizophrenia families (ISHDSF). Neither single-point nor multi-point linkage analysis of NRG1 markers gave evidence for linkage independent of our pre-existing findings telomeric on 8p. Analysis of linkage disequilibrium (LD) across the 252 kb interval encompassing the 7 marker core Icelandic/Scottish NRG1 haplotype revealed two separate regions of modest LD, comprising markers SNP8NRG255133, SNP8NRG249130 and SNP8NRG243177 (telomeric) and microsatellites 478B14-428, 420M9-1395, D8S1810 and 420M9-116I12 (centromeric). From single marker analysis by TRANSMIT and FBAT we found no evidence for association with schizophrenia for any marker. Haplotype analysis for the three SNPs in LD region 1 and, separately, the four microsatellites in LD region 2 (analyzed in overlapping 2-marker windows), showed no evidence for overtransmission of specific haplotypes to affected individuals. We therefore conclude that if NRG1 does contain susceptibility alleles for schizophrenia, they impact quite weakly on risk in the ISHDSF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197397     DOI: 10.1038/sj.mp.4001530

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  24 in total

1.  Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Authors:  Kristin K Nicodemus; Amanda J Law; Eugenia Radulescu; Augustin Luna; Bhaskar Kolachana; Radhakrishna Vakkalanka; Dan Rujescu; Ina Giegling; Richard E Straub; Kate McGee; Bert Gold; Michael Dean; Pierandrea Muglia; Joseph H Callicott; Hao-Yang Tan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes.

Authors:  Alexis C Edwards; Tim B Bigdeli; Anna R Docherty; Silviu Bacanu; Donghyung Lee; Teresa R de Candia; Arden Moscati; Dawn L Thiselton; Brion S Maher; Brandon K Wormley; Dermot Walsh; Francis A O'Neill; Kenneth S Kendler; Brien P Riley; Ayman H Fanous
Journal:  Schizophr Bull       Date:  2015-08-27       Impact factor: 9.306

Review 3.  Genomic structural variation and schizophrenia.

Authors:  Jennifer Gladys Mulle
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

4.  Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas.

Authors:  Tilo Kircher; Renate Thienel; Michael Wagner; Martina Reske; Ute Habel; Thilo Kellermann; Ingo Frommann; Sibylle Schwab; Wolfgang Wölwer; Martina von Wilmsdorf; Dieter F Braus; Andrea Schmitt; Alexander Rapp; Tony Stöcker; N Jon Shah; Fritz A Henn; Heinrich Sauer; Wolfgang Gaebel; Wolfgang Maier; Frank Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

5.  Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism.

Authors:  M Shibuya; E Komi; R Wang; T Kato; Y Watanabe; M Sakai; M Ozaki; T Someya; H Nawa
Journal:  J Neural Transm (Vienna)       Date:  2010-06-05       Impact factor: 3.575

Review 6.  Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.

Authors:  Anamika Banerjee; Mathew L Macdonald; Karin E Borgmann-Winter; Chang-Gyu Hahn
Journal:  Brain Res Bull       Date:  2010-04-28       Impact factor: 4.077

7.  Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder.

Authors:  Falk W Lohoff; John P Dahl; Thomas N Ferraro; Steven E Arnold; Jürgen Gallinat; Thomas Sander; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

Review 8.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Authors:  N Craddock; M C O'Donovan; M J Owen
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

9.  Schizophrenia-related neuregulin-1 single-nucleotide polymorphisms lead to deficient smooth eye pursuit in a large sample of young men.

Authors:  Nikolaos Smyrnis; Emmanouil Kattoulas; Nicholas C Stefanis; Dimitrios Avramopoulos; Costas N Stefanis; Ioannis Evdokimidis
Journal:  Schizophr Bull       Date:  2009-12-04       Impact factor: 9.306

10.  Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals.

Authors:  Tilo Kircher; Axel Krug; Valentin Markov; Carin Whitney; Sören Krach; Klaus Zerres; Thomas Eggermann; Tony Stöcker; Nadim Jon Shah; Jens Treutlein; Markus M Nöthen; Tim Becker; Marcella Rietschel
Journal:  Hum Brain Mapp       Date:  2009-10       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.